- Home
- CDROW
CDROW
Codere Online Luxembourg S.A.
as 03-27-2025 3:33pm EST
| Founded: | N/A | Country: | Luxembourg |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 24.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.78 - $0.85 | Next Earning Date: | 02-20-2025 |
| Revenue: | $151,877,729 | Revenue Growth: | 51.93% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Codere Online Luxembourg S.A. News
CDROW Breaking Stock News: Dive into CDROW Ticker-Specific Updates for Smart Investing
GuruFocus.com
a month ago
Codere Online Luxembourg SA (CDRO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
GlobeNewswire
a month ago
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2024
GlobeNewswire
a month ago
Codere Online Granted Listing Extension by Nasdaq and to Release Q4-24 Earnings on February 20th
TipRanks
3 months ago
Codere Online Faces Auditor Resignation Amid IT Control Challenges
TipRanks
4 months ago
Codere Online reports Q3 revenue EUR 49.2M vs. EUR 41M last year
Newsfile
a year ago
cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions
CNW Group
a year ago
IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule
GlobeNewswire
a year ago
Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces Accelerates
Compare CDROW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDROW Codere Online Luxembourg S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.